Board meeting scheduled for May 8, 2026 to approve audited standalone financial results for Q4 and FY ended March 31, 2026.
Agenda includes dividend recommendation for FY2026 and appointment of internal auditor for FY2026-27.
Trading window closed from April 1, 2026 until 48 hours after results declaration for designated persons.